CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- 4 Gift CEO & CHAIRMAN gave 50,000 shares (gift)
- 4 Gift CEO & CHAIRMAN gave 100,000 shares (gift)
- 4 Shares withheld for taxes CEO & CHAIRMAN gave up 268,337 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & CHAIRMAN gave up 319,231 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO & CHAIRMAN gave up 317,291 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & CHAIRMAN gave up 316,605 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO & CHAIRMAN gave up 278,257 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 11,806 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 721 shares at $6.48 ($4,672)
- 4 Open-market buy Director bought 750 shares at $6.48 ($4,860)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & CHAIRMAN bought 33,943 shares at $5.07 ($171,921)
- 4 Gift CEO & CHAIRMAN gave 120,000 shares (gift)
Page 2 of 11 · 215 filings